The Effect of Rectus Muscle Re-approximation at Cesarean Delivery on Postoperative Pain

Overview

The Effect of Rectus Muscle Re-approximation on Postoperative Pain Among Primigravida Singleton Pregnancies Who Underwent Elective Cesarean Section: A Randomized Prospective Trial. Cesarean section is the most common surgical procedure performed in women in all around the world. Cesarean delivery rate has increased dramatically worldwide but there is still debate about the optimum operative technique of cesarean section. Rectus muscle reapproximation, or suturing of the rectus muscles, is performed by many obstetricians in several countries, presumably to reduce the risk of persistent rectus muscle diastasis. However, there was a few studies about the short and long term effects of rectus muscle reapproximation in the literature. On this account, the investigators aimed to design a randomized prospective trial about the effect of rectus muscle re-approximation on postoperative pain among primigravida singleton pregnancies who underwent elective cesarean section.

Full Title of Study: “The Effect of Rectus Muscle Re-approximation on Postoperative Pain Among Primigravida Singleton Pregnancies Who Underwent Elective Cesarean Section: A Randomized Prospective Trial”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 31, 2022

Detailed Description

This study is a prospective, randomized controlled trial conducted at Balikesir University Medical Faculty Department of Obstetrics and Gynecology at Balikesir, Turkey between January 2021 and March 2022. The singleton pregnant women undergoing scheduled primary cesarean section who are not in labor and consented to the trial are randomly assigned to receive rectus muscle reapproximation versus no reapproximation. Gestational age is detected by the first day of last menstrual period and confirmed by first trimester ultrasonography measurements. The pregnant women who recruited this study would have no maternal accompanying conditions, such as hypertensive disorders of pregnancy, preterm rupture of membranes, Type 1 diabetes mellitus, gestational diabetes mellitus, reno-vascular disorders, sickle-cell anemia, collagen-vascular diseases, hereditary or acquired thrombophilia, congenital abnormalities and multiple gestations. Randomization would be conducted through sequentially numbered opaque envelopes generate by a study nurse in blocks through a random numbers table, in a 1:1 ratio. Surgical techniques at cesarean section are standardized within the study and included closure of the parietal peritoneum and one-layer uterine closure. For women randomized to rectus muscle reapproximation, surgeons will use 2.0 Vicryl (Ethicon) for continuous suturing to reapproximate the rectus muscles. All surgeries were performed by an attending physician and a resident physician.Intraoperative analgesia was standardized to spinal anesthesia. Postoperative pain management is standardized by using our clinic's postoperative cesarean section protocol.Patients with pain unresponsive to the aforementioned treatment could receive opioids as necessary. Visual analog scale (VAS)scores are assessed through inperson interview in the hospital by a member of the study team at 24 and 48 hours after cesarean section.Total opioid use, total milligrams of nonsteroid antiinflammatory drugs (NSAIDs) and acetaminophen use are also tracked and summed. The primary outcome will be the changes in total NSAID, opioid and acetaminophen use of the patients between the groups (rectus reapproximation and no rectus reapproximation groups). The investigators will also analyze the VAS scores of the patients 24 and 48 hours after surgery between the groups.

Interventions

  • Procedure: Rectus muscle reapproximation at cesarean section
    • Rectus muscle reapproximation: Continuous Suturing of rectus muscles with 2.0 Vicryl (Ethicon) at Cesarean section.

Arms, Groups and Cohorts

  • undergoing rectus muscle reapproximation
    • Primigravida Singleton Pregnancies Who Underwent Elective Cesarean Section with rectus muscle reapproximation procedure
  • not undergoing rectus muscle reapproximation
    • Primigravida Singleton Pregnancies Who Underwent Elective Cesarean Section without rectus muscle reapproximation procedure

Clinical Trial Outcome Measures

Primary Measures

  • Postoperative analgesia
    • Time Frame: postoperative period first 48 hours.
    • Drugs (mg)
  • Operation time
    • Time Frame: During operation
    • Operation time: Hours
  • Changes in hemoglobin level
    • Time Frame: Intraoperative and postoperative period (including postoperative 48 hours)
    • mg/dl
  • Length of hospital stay
    • Time Frame: Throughout postoperative period, an average of 2 days after surgery
    • Length of hospital stay: Days
  • Occurence of postoperative complication
    • Time Frame: Throughout postoperative period, an average of 7 days after surgery
    • Hematoma, dehiscense, blood transfusion, etc.
  • Postoperative pain
    • Time Frame: Visual analog score of the patient after 24 hours after cesarean section
    • Visual Analog Scale Score: Units on a Scale (minimum score: 1- maximum score: 100)
  • Postoperative pain
    • Time Frame: Visual analog score of the patient after 48 hours after cesarean section
    • Visual Analog Scale Score: Units on a Scale (minimum score: 1- maximum score: 100)

Participating in This Clinical Trial

Inclusion Criteria

  • Primigravida pregnancies – Singleton pregnancies – Aged between 18- 45 – Term pregnancy – First cesarean section – Elective – Without any comorbidity (Thyroid disorders, Diabetes Mellitus, Hypertension, Preterm delivery, etc.) Exclusion Criteria:

  • active labor, – Prior cesarean section – chronic analgesia use, – vertical skin incision at cesarean, – allergy to opioid or nonsteroidal anti-inflammatory drugs (NSAIDs), – prior laparotomy, – class III obesity (body mass index above 40).

Gender Eligibility: Female

Yes: Eligibility is based on gender

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Balikesir University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Orkun Cetin, Associate Professor – Balikesir University
  • Overall Contact(s)
    • Orkun Çetin, 05325910205, drorkuncetin34@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.